Anterior Uveitis Treatment Market 2027 By Therapeutic, Distribution channel and Geography | The Insight Partners

Anterior Uveitis Treatment Market to 2027 - Global Analysis and Forecasts By Therapeutic (Corticosteroids (prednisolone), Anti-inflammatory agents, Cycloplegics (atropine or homatropine), Antimetabolites (methotrexate), Anti-virals (aciclovir or valaciclovir), Anti-diabetic (metformin), Biologics (mAbs), Others); Distribution channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) and Geography

Report Code: TIPRE00006723 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Eye inflammation to the middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue) is called as anterior uveitis. Anterior uveitis may cause permanent eye damage such as glaucoma, retinal edema or cataract or loss of vision. Eye drops containing anti-inflammatory drugs is the first line of treatment for anterior uveitis. However, anterior uveitis has a tendency to re-occur. Corticosteroids and biologics are the most preferred treatment options for uveitis. Corticosteroids is the most preferred option over biologics however researchers are currently exploring biological therapies for the treatment of anterior uveitis.


MARKET DYNAMICS

The Anterior Uveitis Treatment market is anticipated to grow in the forecast period owing to driving factors such as rising incidence of anterior uveitis, rising geriatric population, rising investments in development of novel biologics and increased funding from private players. Furthermore, developments in molecular science, improved efficiency with new route of drug administration for the treatment anterior uveitis are also driving the market growth.

MARKET SCOPE

The "Global Anterior Uveitis Treatment Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anterior Uveitis Treatment market with detailed market segmentation by therapeutic, distribution channel, and geography. The global Anterior Uveitis Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anterior Uveitis Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Anterior Uveitis Treatment market is segmented on the basis of therapeutic and distribution channel. Based on therapeutic the market is segmented into Corticosteroids (prednisolone), Anti-inflammatory agents, Cycloplegics (atropine or homatropine), Antimetabolites (methotrexate), Anti-virals (aciclovir or valaciclovir), Anti-diabetic (metformin), Biologics (mAbs), and others. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anterior Uveitis Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anterior Uveitis Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Anterior Uveitis Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anterior Uveitis Treatment market in these regions.


MARKET PLAYERS


The reports cover key developments in the Anterior Uveitis Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Anterior Uveitis Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Anterior Uveitis Treatment market in the global market. Below mentioned is the list of few companies engaged in the Anterior Uveitis Treatment market.

The report also includes the profiles of key Anterior Uveitis Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novartis AG
  •  Santen Pharmaceutical Co., Ltd
  •  AbbVie Inc.
  •  Eyegate Pharmaceuticals, Inc.
  •  Clearside Biomedical, Inc.
  •  Aldeyra Therapeutics, Inc.
  •  Aciont Inc.
  •  Sirion Therapeutics, Inc.
  •  UCB Biopharma S.P.R.L.
  •  Lux Biosciences, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anterior Uveitis Treatment Market - By Therapeutic
1.3.2 Anterior Uveitis Treatment Market - By Distribution channel
1.3.3 Anterior Uveitis Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTERIOR UVEITIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTERIOR UVEITIS TREATMENT MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTERIOR UVEITIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS

6.1. ANTERIOR UVEITIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ANTERIOR UVEITIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTERIOR UVEITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC

7.1. OVERVIEW
7.2. THERAPEUTIC MARKET FORECASTS AND ANALYSIS
7.3. CORTICOSTEROIDS (PREDNISOLONE)
7.3.1. Overview
7.3.2. Corticosteroids (prednisolone) Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY AGENTS
7.4.1. Overview
7.4.2. Anti-inflammatory agents Market Forecast and Analysis
7.5. CYCLOPLEGICS (ATROPINE OR HOMATROPINE)
7.5.1. Overview
7.5.2. Cycloplegics (atropine or homatropine) Market Forecast and Analysis
7.6. ANTIMETABOLITES (METHOTREXATE)
7.6.1. Overview
7.6.2. Antimetabolites (methotrexate) Market Forecast and Analysis
7.7. ANTI-VIRALS (ACICLOVIR OR VALACICLOVIR)
7.7.1. Overview
7.7.2. Anti-virals (aciclovir or valaciclovir) Market Forecast and Analysis
7.8. ANTI-DIABETIC (METFORMIN)
7.8.1. Overview
7.8.2. Anti-diabetic (metformin) Market Forecast and Analysis
7.9. BIOLOGICS (MABS)
7.9.1. Overview
7.9.2. Biologics (mAbs) Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis

8. ANTERIOR UVEITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online pharmacies Market Forecast and Analysis

9. ANTERIOR UVEITIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Anterior Uveitis Treatment Market Overview
9.1.2 North America Anterior Uveitis Treatment Market Forecasts and Analysis
9.1.3 North America Anterior Uveitis Treatment Market Forecasts and Analysis - By Therapeutic
9.1.4 North America Anterior Uveitis Treatment Market Forecasts and Analysis - By Distribution channel
9.1.5 North America Anterior Uveitis Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anterior Uveitis Treatment Market
9.1.5.1.1 United States Anterior Uveitis Treatment Market by Therapeutic
9.1.5.1.2 United States Anterior Uveitis Treatment Market by Distribution channel
9.1.5.2 Canada Anterior Uveitis Treatment Market
9.1.5.2.1 Canada Anterior Uveitis Treatment Market by Therapeutic
9.1.5.2.2 Canada Anterior Uveitis Treatment Market by Distribution channel
9.1.5.3 Mexico Anterior Uveitis Treatment Market
9.1.5.3.1 Mexico Anterior Uveitis Treatment Market by Therapeutic
9.1.5.3.2 Mexico Anterior Uveitis Treatment Market by Distribution channel
9.2. EUROPE
9.2.1 Europe Anterior Uveitis Treatment Market Overview
9.2.2 Europe Anterior Uveitis Treatment Market Forecasts and Analysis
9.2.3 Europe Anterior Uveitis Treatment Market Forecasts and Analysis - By Therapeutic
9.2.4 Europe Anterior Uveitis Treatment Market Forecasts and Analysis - By Distribution channel
9.2.5 Europe Anterior Uveitis Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anterior Uveitis Treatment Market
9.2.5.1.1 Germany Anterior Uveitis Treatment Market by Therapeutic
9.2.5.1.2 Germany Anterior Uveitis Treatment Market by Distribution channel
9.2.5.2 France Anterior Uveitis Treatment Market
9.2.5.2.1 France Anterior Uveitis Treatment Market by Therapeutic
9.2.5.2.2 France Anterior Uveitis Treatment Market by Distribution channel
9.2.5.3 Italy Anterior Uveitis Treatment Market
9.2.5.3.1 Italy Anterior Uveitis Treatment Market by Therapeutic
9.2.5.3.2 Italy Anterior Uveitis Treatment Market by Distribution channel
9.2.5.4 Spain Anterior Uveitis Treatment Market
9.2.5.4.1 Spain Anterior Uveitis Treatment Market by Therapeutic
9.2.5.4.2 Spain Anterior Uveitis Treatment Market by Distribution channel
9.2.5.5 United Kingdom Anterior Uveitis Treatment Market
9.2.5.5.1 United Kingdom Anterior Uveitis Treatment Market by Therapeutic
9.2.5.5.2 United Kingdom Anterior Uveitis Treatment Market by Distribution channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anterior Uveitis Treatment Market Overview
9.3.2 Asia-Pacific Anterior Uveitis Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Anterior Uveitis Treatment Market Forecasts and Analysis - By Therapeutic
9.3.4 Asia-Pacific Anterior Uveitis Treatment Market Forecasts and Analysis - By Distribution channel
9.3.5 Asia-Pacific Anterior Uveitis Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anterior Uveitis Treatment Market
9.3.5.1.1 Australia Anterior Uveitis Treatment Market by Therapeutic
9.3.5.1.2 Australia Anterior Uveitis Treatment Market by Distribution channel
9.3.5.2 China Anterior Uveitis Treatment Market
9.3.5.2.1 China Anterior Uveitis Treatment Market by Therapeutic
9.3.5.2.2 China Anterior Uveitis Treatment Market by Distribution channel
9.3.5.3 India Anterior Uveitis Treatment Market
9.3.5.3.1 India Anterior Uveitis Treatment Market by Therapeutic
9.3.5.3.2 India Anterior Uveitis Treatment Market by Distribution channel
9.3.5.4 Japan Anterior Uveitis Treatment Market
9.3.5.4.1 Japan Anterior Uveitis Treatment Market by Therapeutic
9.3.5.4.2 Japan Anterior Uveitis Treatment Market by Distribution channel
9.3.5.5 South Korea Anterior Uveitis Treatment Market
9.3.5.5.1 South Korea Anterior Uveitis Treatment Market by Therapeutic
9.3.5.5.2 South Korea Anterior Uveitis Treatment Market by Distribution channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anterior Uveitis Treatment Market Overview
9.4.2 Middle East and Africa Anterior Uveitis Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Anterior Uveitis Treatment Market Forecasts and Analysis - By Therapeutic
9.4.4 Middle East and Africa Anterior Uveitis Treatment Market Forecasts and Analysis - By Distribution channel
9.4.5 Middle East and Africa Anterior Uveitis Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anterior Uveitis Treatment Market
9.4.5.1.1 South Africa Anterior Uveitis Treatment Market by Therapeutic
9.4.5.1.2 South Africa Anterior Uveitis Treatment Market by Distribution channel
9.4.5.2 Saudi Arabia Anterior Uveitis Treatment Market
9.4.5.2.1 Saudi Arabia Anterior Uveitis Treatment Market by Therapeutic
9.4.5.2.2 Saudi Arabia Anterior Uveitis Treatment Market by Distribution channel
9.4.5.3 U.A.E Anterior Uveitis Treatment Market
9.4.5.3.1 U.A.E Anterior Uveitis Treatment Market by Therapeutic
9.4.5.3.2 U.A.E Anterior Uveitis Treatment Market by Distribution channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anterior Uveitis Treatment Market Overview
9.5.2 South and Central America Anterior Uveitis Treatment Market Forecasts and Analysis
9.5.3 South and Central America Anterior Uveitis Treatment Market Forecasts and Analysis - By Therapeutic
9.5.4 South and Central America Anterior Uveitis Treatment Market Forecasts and Analysis - By Distribution channel
9.5.5 South and Central America Anterior Uveitis Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anterior Uveitis Treatment Market
9.5.5.1.1 Brazil Anterior Uveitis Treatment Market by Therapeutic
9.5.5.1.2 Brazil Anterior Uveitis Treatment Market by Distribution channel
9.5.5.2 Argentina Anterior Uveitis Treatment Market
9.5.5.2.1 Argentina Anterior Uveitis Treatment Market by Therapeutic
9.5.5.2.2 Argentina Anterior Uveitis Treatment Market by Distribution channel

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTERIOR UVEITIS TREATMENT MARKET, KEY COMPANY PROFILES

11.1. NOVARTIS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANTEN PHARMACEUTICAL CO., LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ABBVIE INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. EYEGATE PHARMACEUTICALS, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CLEARSIDE BIOMEDICAL, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALDEYRA THERAPEUTICS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ACIONT INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SIRION THERAPEUTICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. UCB BIOPHARMA S.P.R.L.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. LUX BIOSCIENCES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Santen Pharmaceutical Co., Ltd
3. AbbVie Inc.
4. Eyegate Pharmaceuticals, Inc.
5. Clearside Biomedical, Inc.
6. Aldeyra Therapeutics, Inc.
7. Aciont Inc.
8. Sirion Therapeutics, Inc.
9. UCB Biopharma S.P.R.L.
10. Lux Biosciences, Inc.